EBS

Emergent Biosolutions (EBS)

Emergent Biosolutions Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:EBS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/12	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/06/12	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/06/12	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/06/12	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/06/07	05:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/06/06	22:02	GlobeNewswire Inc.	Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day	NYSE:EBS	Emergent Biosolutions Inc
2024/06/05	05:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/06/01	04:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/05/29	20:34	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:EBS	Emergent Biosolutions Inc
2024/05/29	10:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/05/29	10:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/05/29	10:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/05/29	10:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/05/29	10:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/05/29	10:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/05/29	10:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/05/24	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/05/10	20:17	GlobeNewswire Inc.	Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024	NYSE:EBS	Emergent Biosolutions Inc
2024/05/02	05:57	GlobeNewswire Inc.	Emergent BioSolutions Reports First Quarter 2024 Financial Results	NYSE:EBS	Emergent Biosolutions Inc
2024/05/02	05:10	GlobeNewswire Inc.	Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position	NYSE:EBS	Emergent Biosolutions Inc
2024/05/02	00:03	GlobeNewswire Inc.	Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone	NYSE:EBS	Emergent Biosolutions Inc
2024/05/01	06:26	GlobeNewswire Inc.	Emergent BioSolutions Announces Amendment to its Existing Credit Facility	NYSE:EBS	Emergent Biosolutions Inc
2024/04/22	21:05	GlobeNewswire Inc.	Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024	NYSE:EBS	Emergent Biosolutions Inc
2024/04/01	21:00	GlobeNewswire Inc.	Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive	NYSE:EBS	Emergent Biosolutions Inc
2024/03/28	21:15	GlobeNewswire Inc.	Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis	NYSE:EBS	Emergent Biosolutions Inc
2024/03/25	21:05	GlobeNewswire Inc.	Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility	NYSE:EBS	Emergent Biosolutions Inc
2024/03/09	06:21	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NYSE:EBS	Emergent Biosolutions Inc
2024/03/08	10:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EBS	Emergent Biosolutions Inc
2024/03/07	06:31	GlobeNewswire Inc.	Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results	NYSE:EBS	Emergent Biosolutions Inc
2024/03/07	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:EBS	Emergent Biosolutions Inc